Paper Detail
C
IF
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals (Basel, Switzerland) 14: ., 2021.  [Review] 
 doi: 10.3390/ph14030280 PMID: 33804613.
 
Send Email
From
To
Subject